Life Science Intelligenceの


Life Science Intelligenceのdatabase新着情報:


U.S. Markets for Cardiac Rhythm Management Products
Cardiac rhythm disorders-also called arrhythmias or dysrhythmias-encompass a variety of relatively common chronic conditions characterized by recurrent distortions in the electrical and contractile activity of the heart, which may cause clinically significant and progressive hemodynamic deficits and cardiopulmonary impairment, and lead to the onset of catastrophic events such as stroke or cardiac arrest.
Acute and chronic arrhythmias afflict cumulatively more than 8 million people in the U.S., accounting for over 20% of all medical conditions treated by cardiologists. Furthermore, each year cardiac rhythm disorders represent a primary or secondary cause of death in nearly 600,000 American mortalities and prompt approximately 1.5 million hospitalizations, resulting in an estimated $35 billion in direct and indirect annual healthcare costs.
The scope of this report covers critical device-based arrhythmia diagnostic and therapeutic systems that are routinely employed in the management of patients with such conditions as debilitating bradycardia and heart block, life-threatening atrial and ventricular tachyarrhythmias, cardiac asynchrony associated with progressing heart failure, arrhythmia-induced cardiogenic shock and sudden cardiac arrest.
The U.S. Cardiac Rhythm Management Products Market totaled more than $7.9 billion in 2009 and despite prevailing economic conditions is expected to grow at a healthy 4.8% compound annual rate, reaching more than $10.0 billion in 2014.

This Report Contains: Procedure volumes, units sold and ASPs, current and forecast market size, competitor shares (units, revenues), trends and opportunities, emergingtechnologies, patient populations, + more.

U.S. Opportunities in Pulmonary Medicine Technologies 2010
·Electromagnetic navigation bronchoscopy systems
·Diagnostic spirometers
·Pulmonary function equipment
·Acoustic diagnostic technologies
·Computer-aided detection systems
·Mini-BAL kits
·Exhaled breath analysis technologies
·Peak flow meters
·Oxygen concentrators
·Lung assist technologies
·High flow nasal oxygen therapy products
·Airway stents
·Chest compression systems
·Bronchial thermotherapy
·Airway bypass
·Interventional lung volume reduction technologies
·Diaphragm pacing systems

Single: $4,750
Corporate: $8,550
Date Published: September 2010


FAX: 0551-20-5531